Abstract
Classically, drug-loaded poly(alkylcyanoacrylate) colloidal carriers are prepared by the drug entrapment during emulsion polymerization. However, a number of chemically sensitive drugs are unstable in the conditions of polymerization or can be irreversibly inactivated by the highly reactive monomer. Furthermore, the particle size distribution and the molecular weight of formed polymer depend strongly on the polymerization conditions. Here, we investigate the nanoprecipitation approach for the preparation of pure and drug-load poly(butylcyanoacrylate) nanoparticles. This method allows the successful entrapment of lipophilic and chemically labile drugs by avoiding the contact with highly reactive monomers. The anticancer agent chlorambucil is chosen as the model drug for the incorporation and release studies. Pure and drug-loaded nanoparticles are successfully prepared using various stabilizers (Polysorbate 80, Pluronic F68, Dextran 40). The nanoparticles coated with Polysorbate 80 are of highest interest since they could overcome the blood–brain barrier and the multidrug resistance in cancer cells. Such nanoparticles can be easily prepared by the nanoprecipitation approach reported here.
References
Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P (2003) Adv Drug Deliv Rev 55:519–548
Garcia-Garcia E, Andrieux K, Gil S, Couvreur P (2005) Int J Pharm 298:274–292
Vauthier C, Labarre D, Ponchel G (2007) J Drug Target 15:641–663
Oowaki H, Matsuda S, Sakai N, Ohta T, Iwata H, Sadato A, Taki W, Hashimoto N, Ikada Y (2000) Biomaterials 21:1039–1046
Murthy R, Reddy L (2006) Poly(Alkyl Cyanoacrylate) nanoparticles for delivery of anti-cancer drugs. In: Amiji MM (ed) Nanotechnology for cancer therapy. CRC, Boca Raton, pp 251–288
Arias J, Ruiz A, Lopez-Viota M, Delgado A (2008) Colloid Surface B 62:64–70
Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R, Kreuter J, Gelperina S (2007) J Control Release 117:51–58
Kreuter J, Alyautdin R, Kharkevich D, Ivanov A (1995) Brain Res 674:171–174
Arias J, Gallardo V, Ruiz A, Delgado A (2008) Eur J Pharm Biopharm 69:54–63
Gulyaev A, Ermekbaeva B, Kivman G, Radchenko T, Sherstov A, Shirinskii V (1998) Pharm Chem J 32:3
Pinto-Alphandary H, Andremont A, Couvreur P (2000) Int J Antimicrob Ag 13:155–168
Fattal E, Youssef M, Couvreur P, Andremont A (1989) Antimicrob Agents Chemother 33:1540–1543
Kisich K, Gelperina S, Higgins M, Wilson S, Shipulo E, Oganesyan E, Heifets L (2007) Int J Pharm 345:154–162
Fontana G, Licciardi M, Mansueto S, Schillaci D, Giammona G (2001) Biomaterials 22:2857–2865
Cavallaro G, Fresta M, Giammona G, Puglisi G, Villari A (1994) Int J Pharm 111:31–41
Zhang Q, Shen Z, Nagai T (2001) Int J Pharm 218:75–80
Graf A, Jack K, Whittaker A, Hook S, Rades T (2008) Eur J Pharm Sci 33:434–444
Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P (2000) Pharm Res 17(6):707–714
Briesen H, Ramge P, Kreuter J (2000) AIDS Rev 2:31–38
Kuo Y (2005) Int J Pharm 290:161–172
Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P (1979) J Pharm Pharmacol 31:331–332
Douglas SJ, Illum L, Davis SS, Kreuter J (1984) J Colloid Interface Sci 101:149–158
Douglas SJ, Illum L, Davis SS (1985) J Colloid Interface Sci 103:154–163
Vansnick L, Couvreur P, Christiaensleyh D, Roland M (1985) Pharm Res 1:36–41
El-Egakey MA, Bentele V, Kreuter J (1983) Int J Pharm 13:349–352
Lescure F, Zimmer C, Roy D, Couvreur P (1992) J Colloid Interface Sci 154:77–86
Douglas SJ, Davis SS, Holding SR (1985) Br Polym J 17:339–342
Alonso MJ, Sanchez A, Torres D, Seijo B, Vila-Jato JL (1990) J Microencapsul 7:517–526
Guise V, Drouin JY, Benoit J, Mahuteau J, Dumont P, Couvreur P (1990) Pharm Res 7:736–741
Grangier JL, Puygrenier M, Gautier JC, Couvreur P (1991) J Control Release 15:3–13
Page-Clisson ME, Pinto-Alphandary H, Ourevitch M, Andremont A, Couvreur P (1998) J Control Release 56:23–32
Thioune O, Fessi H, Devissaguet JP, Puisieux F (1997) Int J Pharm 146:233–238
Ganachaud F, Katz JL (2005) Chem Phys Chem 6:209–216
Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, D’Angelo J, Cattel L, Couvreur P (2000) J Pharm Sci 89:1452–1464
Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao XJ, Zhu JH (2001) Biol Pharm Bull 24:662–665
Calvo P, Gouritin B, Brigger I, Lasmezas C, Deslys J, Williams A, Andreux JP, Dormont D, Couvreur P (2001) J Neurosci Methods 111:151–155
Fernandez-Urrusuno R, Fattal E, Porquet D, Feger J, Couvreur P (1995) Toxicol Appl Pharmacol 130:272–279
Vezin WR, Florence A (1980) J Biomed Mater Res 14:93–106
Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Biomaterials 5:65–68
Muller R, Lherm C, Herbort J, Couvreur P (1990) Biomaterials 11:590–595
Treupel L, Poupon M, Couvreur P, Puisieux F (1991) CR Acad Sci III 313:171–174
Cuvier C, Roblot-Treupel L, Millot J, Lizard G, Chevillard S, Manfait M, Couvreur P, Poupon M (1992) Biochem Pharm 44:509–517
Bennis S, Chapey C, Robert J, Couvreur P (1994) Eur J Cancer 30:89–93
Kreuter J (2001) Adv Drug Deliv Rev 47:65–81
Ramge P, Unger R, Oltrogge J, Zenker D, Begley D, Kreuter J, Briesen H (2000) Eur J Neurosci 12:1931–1940
Gulyaev A, Gelperina S, Skidan I, Antropov A, Kivman G, Kreuter J (1999) Pharm Res 16:1564–1569
Gelperina S, Khalansky A, Skidan I, Smirnova Z, Bobruskin A, Severin S, Turowski B, Zanella F, Kreuter J (2002) Toxicol Lett 126:131–141
Hawley A, Davis S, Illum L (1995) Adv Drug Deliv Rev 17:129–148
Moghimi S, Bonnemain B (1999) Adv Drug Deliv Rev 37:295–312
Nishioka Y, Yoshino H (2001) Adv Drug Deliv Rev 47:55–64
Oussoren C, Storm G (2001) Adv Drug Deliv Rev 50:143–156
Hall A, Tilby M (1992) Blood Rev 6:163–173
Ehrsson H, Eksborg S, Wallin I, Nilsson S (1980) J Pharm Sci 69:1091–1094
Bosanquet A, Clarke H (1986) Cancer Chemoth Pharm 18:176–179
Sharma P, Ganta S, Denny W, Garg S (2009) Int J Pharm 367:187–194
Acknowledgment
The authors are thankful to COST Action D43 of the European Community.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yordanov, G.G., Dushkin, C.D. Preparation of poly(butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers. Colloid Polym Sci 288, 1019–1026 (2010). https://doi.org/10.1007/s00396-010-2226-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00396-010-2226-6